HomeRCUS • NYSE
add
Arcus Biosciences Inc
Previous close
$13.01
Day range
$13.03 - $13.56
Year range
$12.83 - $20.31
Market cap
1.22B USD
Avg Volume
660.46K
P/E ratio
-
Dividend yield
-
Primary exchange
NYSE
Financials
Income Statement
Revenue
Net income
| (USD) | Sep 2024info | Y/Y change |
|---|---|---|
Revenue | 48.00M | 50.00% |
Operating expense | 30.00M | 0.00% |
Net income | -92.00M | -29.58% |
Net profit margin | -191.67 | 13.62% |
Earnings per share | -1.00 | -6.38% |
EBITDA | -103.00M | -30.38% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Sep 2024info | Y/Y change |
|---|---|---|
Cash and short-term investments | 1.09B | 36.30% |
Total assets | 1.25B | 5.12% |
Total liabilities | 687.00M | 2.38% |
Total equity | 565.00M | — |
Shares outstanding | 91.51M | — |
Price to book | 2.11 | — |
Return on assets | -21.53% | — |
Return on capital | -40.70% | — |
Cash Flow
Net change in cash
| (USD) | Sep 2024info | Y/Y change |
|---|---|---|
Net income | -92.00M | -29.58% |
Cash from operations | 26.00M | 141.27% |
Cash from investing | -29.00M | -363.64% |
Cash from financing | 48.00M | 700.00% |
Net change in cash | 45.00M | 197.83% |
Free cash flow | -15.25M | 73.54% |
About
Founded
2015
Website
Employees
577
